News & Updates

Welldoc® Executives and Thought Leaders to Present at Upcoming Industry Conferences

April 5, 2018

Colum­bia, Mary­land, April 4, 2018 – Well­doc®, a lead­ing dig­i­tal ther­a­peu­tics com­pa­ny, announced today that its exec­u­tives and dig­i­tal health, dia­betes and health­care indus­try thought lead­ers will speak and/or par­tic­i­pate in pan­el dis­cus­sions at promi­nent dia­betes and health­care con­fer­ences this Spring. The list of events is as fol­lows:

Johns Hop­kins Clin­i­cal Con­tin­u­ing Edu­ca­tion Series
April 4, 2018, Johns Hop­kins Uni­ver­si­ty, Bal­ti­more, MD
Jan­ice MacLeod, MA, RDN, LDN, CDE, will present “The Brave New World of Dia­betes Edu­ca­tion: Remod­el­ing Your Prac­tice in an Evolv­ing Health­care Envi­ron­ment” at 2:00 p.m. ET.

Flori­da Health Care Coali­tion 25th Annu­al Con­fer­ence
April 10, 2018, Rosen Cen­tre Hotel, Orlan­do, FL
Well­doc Chief Strat­e­gy Offi­cer Anand K. Iyer, PhD, MBA, will present “Dig­i­tal Ther­a­peu­tics: Hit­ting the Sweet Spot in Dia­betes – Engag­ing Patients, Deliv­er­ing Out­comes” at 10:45 a.m. ET.

2018 Bio­Health Cap­i­tal Region Forum
April 23 – 24, 2018, Med­Im­mune, Gaithers­burg, MD
Well­doc Chief Exec­u­tive Offi­cer Kevin McRaith will present on April 23.

Dig­i­tal Ther­a­peu­tics in the NHS Sum­mit
April 24, 2018, Caris­brooke Hall, Lon­don, UK
Dr. Iyer will par­tic­i­pate in the pan­el dis­cus­sion “Inter­ro­gat­ing the Evi­dence.”

2018 Health Dat­a­palooza
April 26 – 27, 2018, Wash­ing­ton Hilton, Wash­ing­ton, D.C.
Ms. MacLeod will present on April 27 at 9:15 a.m. ET.

MBGH 38th Annu­al Con­fer­ence
May 2 – 3, 2018, The Mid-Amer­i­ca Club, Chica­go, IL
Well­doc Chief Rev­enue Offi­cer Lau­rel Pick­er­ing, MPH, will present “Dig­i­tal Health: A tool to engage peo­ple and low­er cost” on May 2 at 1:15 p.m. CT.

Mem­phis Busi­ness Group on Health
May 2, 2018, Mem­phis Busi­ness Group on Health, Mem­phis, TN
Ms. MacLeod will present at 8:30 a.m. CT.

Employ­ers’ Health Coali­tion
May 16, 2018, Kent State Uni­ver­si­ty, Stark Cam­pus, Can­ton, OH
Ms. Pick­er­ing will present “Dig­i­tal Health: A tool to engage peo­ple and low­er cost.”

Dia­betes Tech­nol­o­gy Soci­ety Dig­i­tal Dia­betes Con­gress
May 22 – 23, 2018, Marines’ Memo­r­i­al Club & Hotel, San Fran­cis­co, CA
Dr. Iyer will par­tic­i­pate in the pan­el dis­cus­sion “Reg­u­la­to­ry Aspects of Dig­i­tal Health” on May 22 at 2:05 p.m. PT.

About BlueS­tar®

BlueS­tar®, pow­ered by Well­doc®, is an FDA-cleared, proven dig­i­tal ther­a­peu­tic that is an in-app coach engag­ing peo­ple with type 2 dia­betes. It deliv­ers per­son­al­ized, real-time feed­back, as well as dia­betes edu­ca­tion­al tools that are action­able and indi­vid­u­al­ized. Specif­i­cal­ly, Well­doc has devel­oped more than 30 peer-reviewed pub­li­ca­tions and pre­sen­ta­tions on BlueS­tar, includ­ing two ran­dom­ized, con­trolled clin­i­cal tri­als. Our clin­i­cal evi­dence shows a 1.7 to 2.0-point mean A1C reduc­tion for adults liv­ing with type 2 dia­betes who used BlueS­tar. In Novem­ber 2017, the IQVIA Insti­tute for Human Data Sci­ence (for­mer­ly Quintiles/IMS) named BlueS­tar the “top app” in clin­i­cal dia­betes treat­ment. BlueS­tar deliv­ers an esti­mat­ed aver­age cost sav­ings of $254-$271 per user per month, proven clin­i­cal out­comes and a net pro­mot­er mem­ber sat­is­fac­tion score of 70. For more infor­ma­tion on BlueS­tar, vis­it: www2.bluestardiabetes.com.

This year, Sam­sung Elec­tron­ics Amer­i­ca, Inc. and Well­doc announced that Sam­sung Health users now have access to a new con­sumer ver­sion of Welldoc’s dig­i­tal plat­form known as the Dia­betes Well­ness Pro­gram (DWP). The DWP, which is inte­grat­ed with­in the Sam­sung Health ser­vice, is a 12-week health and well­ness pro­gram designed to help adults with type 2 dia­betes achieve a healthy lifestyle and to help man­age their con­di­tion. More infor­ma­tion
on DWP is avail­able at: www.welldoc.com/diabeteswellness

About Well­doc®

Well­doc® is a lead­ing dig­i­tal ther­a­peu­tic com­pa­ny rev­o­lu­tion­iz­ing chron­ic dis­ease man­age­ment to help trans­form lives. Our ground­break­ing tech­nol­o­gy is guid­ing indi­vid­u­als through the com­pli­cat­ed jour­ney of liv­ing with chron­ic dis­eases, with a goal of help­ing indi­vid­u­als self-man­age their con­di­tions to achieve sig­nif­i­cant clin­i­cal out­comes and cost sav­ings. We began our jour­ney by mas­ter­ing dia­betes man­age­ment solu­tions and are mov­ing rapid­ly into cre­at­ing addi­tion­al tools for man­ag­ing oth­er chron­ic dis­eases includ­ing hyper­ten­sion, chron­ic obstruc­tive pul­monary dis­ease (COPD) and con­ges­tive heart fail­ure (CHF). We are the first dig­i­tal health com­pa­ny based on a life sci­ence busi­ness mod­el with a foun­da­tion that is built on ran­dom­ized clin­i­cal tri­als that demon­strate sig­nif­i­cant clin­i­cal out­comes. We have tak­en an aggres­sive and inno­v­a­tive approach that uti­lizes sophis­ti­cat­ed log­ic, pre­cise algo­rithms, and arti­fi­cial intel­li­gence (AI), which inte­grates the most advanced mobile tech­nol­o­gy and behav­ioral insights. Well­doc part­ners with, col­lab­o­rates with, and is backed by top health­care com­pa­nies (includ­ing Mer­ck and John­son and John­son), lead­ing inno­va­tors, ded­i­cat­ed investors, and top mobile tech­nol­o­gy com­pa­nies (such as Sam­sung).